Getinge AB (publ) (OTCMKTS:GNGBY – Get Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $20.30 and traded as high as $22.15. Getinge AB (publ) shares last traded at $22.08, with a volume of 5,574 shares.
Getinge AB (publ) Stock Performance
The company has a current ratio of 0.78, a quick ratio of 0.50 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $6.01 billion, a PE ratio of 38.73 and a beta of 0.81. The firm’s 50-day simple moving average is $20.30 and its two-hundred day simple moving average is $18.76.
Getinge AB (publ) (OTCMKTS:GNGBY – Get Free Report) last announced its quarterly earnings data on Tuesday, January 28th. The company reported $0.49 EPS for the quarter. Getinge AB (publ) had a net margin of 4.71% and a return on equity of 9.84%.
Getinge AB (publ) Increases Dividend
About Getinge AB (publ)
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.
Further Reading
- Five stocks we like better than Getinge AB (publ)
- What Do S&P 500 Stocks Tell Investors About the Market?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Breakout Stocks: What They Are and How to Identify Them
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Getinge AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.